Media Coverage

2021

23/07/2021

6PR (Audio) – Proteomics: Predicting a disease before you get it – now that’s novel

22/07/2021

Proteomics International engages Abcam to manufacture PromarkerD reagents – Proactive Investors

16/07/2021

Proteomics International Laboratories (ASX:PIQ) shows diabetes drug improves PromarkerD risk scores – The Market Herald

28/06/2021

Vast US market opportunity seen for Proteomics kidney test – The West Australian

19/05/2021

Proteomics nails Avance testing contract – The West Australian

10/02/2021

PromarkerD: Predicting Diabetic Kidney Disease Before Symptoms Arrive – Medical Forum Magazine

09/02/2021

Proteomics International (ASX:PIQ) pursues FDA approval for PromarkerD – The Market Herald

09/02/2021

Proteomics seeks FDA approval for blood test kit – The West Australian

2020

16/12/2020

Proteomics International interviewed for Australian Government R&D Tax Incentive podcast

12/11/2020

Proteomics International Inks Israeli Distribution Deal for Diabetic Kidney Disease Immunoassay – 360Dx

12/11/2020

Proteomics inks kidney disease test deal in Mid-East – The West Australian

05/11/2020

Clinical assay performance validates Proteomics kidney test – The West Australian

05/11/2020

Proteomics: ‘Studies Back PromarkerD For Kidney Disease’ – Biotech Daily

04/11/2020

$1.1m tax rebate booster for Proteomics coffers – The West Australian

03/11/2020

Proteomics International Laboratories (ASX:PIQ) receives $1.1M R&D tax refund – The Market Herald

Subscribe
  • This field is for validation purposes and should be left unchanged.